AstraZeneca PLC – ADR To Join The NASDAQ-100 Index Beginning February 22, 2022

Nasdaq (Nasdaq: NDAQ) today announced that AstraZeneca PLC – ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. (Nasdaq: XLNX) in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index.

For more information about the company, go to https://www.astrazeneca.com.